- California Assembly OKs highest minimum wage in nation
- S. Korea unveils first graphic cigarette warnings
- US joins with South Korea, Japan in bid to deter North Korea
- LPGA golfer Chun In-gee finally back in action
- S. Korea won’t be top seed in final World Cup qualification round
- US men’s soccer misses 2nd straight Olympics
- US back on track in qualifying with 4-0 win over Guatemala
- High-intensity workout injuries spawn cottage industry
- CDC expands range of Zika mosquitoes into parts of Northeast
- Who knew? ‘The Walking Dead’ is helping families connect
Ebola drug shows some promise in first tests in West Africa
SEATTLE (AP) — An experimental antiviral drug shows some early, encouraging signs of effectiveness in its first human test against Ebola in West Africa, but only if patients get it when their symptoms first appear.
A study of the drug, favipiravir (fav-ih-PEER-ah-veer), is still in early stages in West Africa, and too few people have been treated to really know whether the drug helps. Other factors, like better health care, may be making a difference, and there was no comparison group of patients who got no treatment or a different drug.
Results for the first 69 adults and teens in Guinea were released Monday. Among those who got the drug when virus levels were still low, survival was 85 percent. That seems better than the roughly 70 percent survival for patients treated in the same clinics two months before the study began, researchers said at the Retrovirus Conference in Seattle.
The drug made no difference for those who got it later. Unfortunately, the median time of symptoms when patients sought care was five days, and the infection often is well established by then.
“We have preliminary evidence” that favipiravir may be effective, says a statement by Carlos Moedas, European Commissioner for Research, Science and Innovation, which helped fund the work. “If these results are confirmed by the ongoing clinical trial, it will be the first-ever treatment to be deployed against this deadly disease during the current outbreak.”
The current Ebola outbreak is the largest in history. There have been nearly 23,000 cases and nearly 9,000 deaths, mostly in Liberia, Guinea and Sierra Leone, the World Health Organization estimates.
There are no specific medicines or vaccines to fight the virus, though some experimental ones are being tested. Favirapir, also known by its brand name, Avigan, is made by a Japanese company, Toyama Chemical. It was approved in Japan last year for treating flu and tests suggest it also may work against other viruses.
A French nurse who got Ebola while volunteering in Africa for Doctors Without Borders was treated with favipiravir and recovered.
The new study was launched in December in two Ebola treatment units in Guinea run by that aid group. Others involved in the study include the aid group Alliance for International Medical Action and INSERM, the French public health agency.
Even doctors involved in the study acknowledge that more research is needed to determine the drug’s safety and effectiveness.
In some previous Ebola outbreaks and even in this one, survival has improved as time goes on and cases are detected and treated sooner, and more care becomes available. In December, doctors reported that survival among nearly 600 recent Ebola patients in Sierra Leone was about 70 percent, compared to only about 26 percent earlier in the outbreak. Among those treated more recently, survival was over 76 percent.
Pengobatan Sipilis Tanpa Ke Dokter
April 27, 2017 at 7:09 AM
Excellent information. This really made me add knowledge. Thank you very much. Hope Always update
Apa Obat Di Apotik Untuk Penyakit Sipilis
April 28, 2017 at 6:57 PM
Excellent information. This really made me add knowledge. Thank you very much. Hope Always update
Apa Penyebab Kencing Mengeluarkan Nanah
May 22, 2017 at 7:35 PM
True, this is what I think too. Although somewhat different in opinion about the discussion, but mostly I agree with this site. Hope it always updates so I always increase my insight
Keluar air nanah dari kemaluan
May 22, 2017 at 8:20 PM
I always like what in this site post, always provide the information I need. Hope it always updates so I can add my insight from this site. Thank you